SUV
primary malignancies, SUVFor primary malignant lesions
Our team previously designed an algorithm, which has been patented (Patent number: US11189374B2) [Linear relationship between SUVFor primary malignant lesions, the median T/B ratio and SUVUptake of [The ROC curve built with 67 malignant lesions (38 primary malignancies and 29 metastatic lesions) and 48 benign lesions yielded an AUC of 0.938 (95% CI, 0.895–0.981, The performance of T/B ratio (red line) and SUV